These findings comprehensively support the hypothesized link between elevated CD38 expression, extracellular ADO production, and the PD-1/PD-L1 axis in all mature B-cell lymphoma patients. This evidence concerns the gene ADO and B-cell non-Hodgkin lymphoma.